- Home
- SI vs OSUR Comparison
SI vs OSUR Comparison
Compare SI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SI
- OSUR
- Stock Information
- Founded
- SI 2009
- OSUR 2000
- Country
- SI United States
- OSUR United States
- Employees
- SI N/A
- OSUR N/A
- Industry
- SI Medical/Dental Instruments
- OSUR Medical/Dental Instruments
- Sector
- SI Health Care
- OSUR Health Care
- Exchange
- SI Nasdaq
- OSUR Nasdaq
- Market Cap
- SI 257.1M
- OSUR 229.7M
- IPO Year
- SI 2025
- OSUR 1986
- Fundamental
- Price
- SI $15.63
- OSUR $3.32
- Analyst Decision
- SI Strong Buy
- OSUR Hold
- Analyst Count
- SI 4
- OSUR 1
- Target Price
- SI $18.75
- OSUR $3.00
- AVG Volume (30 Days)
- SI 285.1K
- OSUR 618.4K
- Earning Date
- SI 01-17-2023
- OSUR 08-05-2025
- Dividend Yield
- SI N/A
- OSUR N/A
- EPS Growth
- SI N/A
- OSUR N/A
- EPS
- SI N/A
- OSUR N/A
- Revenue
- SI $34,571,000.00
- OSUR $138,533,000.00
- Revenue This Year
- SI N/A
- OSUR N/A
- Revenue Next Year
- SI N/A
- OSUR $5.35
- P/E Ratio
- SI N/A
- OSUR N/A
- Revenue Growth
- SI 64.07
- OSUR N/A
- 52 Week Low
- SI $11.75
- OSUR $2.36
- 52 Week High
- SI $17.94
- OSUR $4.61
- Technical
- Relative Strength Index (RSI)
- SI N/A
- OSUR 61.84
- Support Level
- SI N/A
- OSUR $2.76
- Resistance Level
- SI N/A
- OSUR $3.54
- Average True Range (ATR)
- SI 0.00
- OSUR 0.15
- MACD
- SI 0.00
- OSUR 0.07
- Stochastic Oscillator
- SI 0.00
- OSUR 72.50
About SI Shoulder Innovations Inc. Common Stock
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.